Financials
- Market Capitalization 539.57 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.25
ratio cours/chiffre d'affaires
1.9
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2425 | CSTL Castle Biosciences, Inc. - Common stock | 33.52 USD | +1.48% | -4.23% | +20.45% | +36.18% | 1.02 B USD | ||
| 2515 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 6.02 USD | -0.50% | -7.95% | +15.99% | +210.31% | 886.14 M USD | ||
| 3016 | PRE Prenetics Global Limited - Class A Ordinary Share | 25.67 USD | -2.21% | +10.41% | +31.98% | +224.94% | 433.16 M USD | ||
| 3334 | MYGN Myriad Genetics, Inc. - Common Stock | 3.19 USD | -0.93% | 0.00% | +11.54% | -61.43% | 305.12 M USD |